You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

OMEPRAZOLE AND SODIUM BICARBONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Omeprazole And Sodium Bicarbonate, and what generic alternatives are available?

Omeprazole And Sodium Bicarbonate is a drug marketed by Ajanta Pharma Ltd, Anda Repository, Aurobindo Pharma, Aurolife Pharma Llc, Chartwell Rx, Dr Reddys, Perrigo R And D, Sciegen Pharms Inc, Strides Pharma, Zydus, and Zydus Pharms. and is included in fifteen NDAs.

The generic ingredient in OMEPRAZOLE AND SODIUM BICARBONATE is omeprazole; sodium bicarbonate. There are one hundred and thirty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the omeprazole; sodium bicarbonate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Omeprazole And Sodium Bicarbonate

A generic version of OMEPRAZOLE AND SODIUM BICARBONATE was approved as omeprazole; sodium bicarbonate by STRIDES PHARMA on April 19th, 2013.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OMEPRAZOLE AND SODIUM BICARBONATE?
  • What are the global sales for OMEPRAZOLE AND SODIUM BICARBONATE?
  • What is Average Wholesale Price for OMEPRAZOLE AND SODIUM BICARBONATE?
Summary for OMEPRAZOLE AND SODIUM BICARBONATE
US Patents:0
Applicants:11
NDAs:15
Finished Product Suppliers / Packagers: 25
Clinical Trials: 12
What excipients (inactive ingredients) are in OMEPRAZOLE AND SODIUM BICARBONATE?OMEPRAZOLE AND SODIUM BICARBONATE excipients list
DailyMed Link:OMEPRAZOLE AND SODIUM BICARBONATE at DailyMed
Drug patent expirations by year for OMEPRAZOLE AND SODIUM BICARBONATE
Recent Clinical Trials for OMEPRAZOLE AND SODIUM BICARBONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Food and Drug Administration (FDA)Phase 1
BioPharma Services, IncPhase 1
Ajou University School of MedicinePhase 1

See all OMEPRAZOLE AND SODIUM BICARBONATE clinical trials

US Patents and Regulatory Information for OMEPRAZOLE AND SODIUM BICARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 204228-001 Jul 15, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 203290-001 May 25, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 079182-002 Apr 19, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurolife Pharma Llc OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 204922-002 Aug 19, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Anda Repository OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 212587-002 Apr 30, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 207476-001 Dec 6, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ajanta Pharma Ltd OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 205545-001 Jul 27, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.